The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Bal Pharma Share Price
Bal Pharma (INR)118.721.3 (1.1%) 
Exchange ScripsBSE524824NSEBALPHARMAISININE083D01012
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Bal Pharma Performance
Market performance
Open price117.95
High119
Volumes11286
Prev Close118.72
Low114.65
Closing date2025-01-10
Historical performance
1 Year High157.98
3 Year High157.98
5 Year High157.98
1 Year Low88.95
3 Year Low63.35
5 Year Low23.00
Bal Pharma Fundamentals
Company Valuation
Market Cap (₹Cr)
189
Face Value (₹)
10
P/E Ratio
25.38
Dividend Yield
0.1 %
Bal Pharma Investment Returns
1 Year
4.6%
3 Years
-3.9%
5 Years
176.1%
10 Years
69.4%
Bal Pharma Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 120.59 | Bearish |
| 10-DMA | 123.05 | Bearish |
| 20-DMA | 122.42 | Bearish |
| 50-DMA | 123.88 | Bearish |
| 100-DMA | 128.15 | Bearish |
| 200-DMA | 119.07 | Bearish |
Shareholding Pattern
| Field | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sep-2023 |
|---|---|---|---|---|---|
| Promoters | 11 | 11 | 11 | 11 | 11 |
| Foreign Investors | 3 | 3 | 3 | 3 | 3 |
| Domestic Investors | 8 | 8 | 8 | 8 | 8 |
| Public Investors | 15996 | 15003 | 14761 | 15049 | 15518 |
| Government | --- | --- | --- | --- | --- |
Bal Pharma Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 28 | 9 | 52 | 11 |
| Operating Profit | 346 | 262 | 291 | 258 |
| Interest | 154 | 123 | 109 | 122 |
| Depreciation | 101 | 91 | 90 | 95 |
| Profit Before Tax | 90 | 47 | 92 | 41 |
| Consolidated Net Profit | 74 | 26 | 56 | 47 |
| Adjusted EPS | 5 | 2 | 4 | 3 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 158 | 157 | 148 | 148 |
| Total Reserves | 535 | 481 | 429 | 378 |
| Minority Interest | --- | -1 | -1 | -2 |
| Total Non-Current Liabilities | 448 | 380 | 364 | 342 |
| Total Liabilities | 3171 | 3110 | 2605 | 2401 |
| Capital Work in Progress | 5 | --- | 16 | --- |
| Total Assets | 3171 | 3110 | 2605 | 2401 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 228 | -15 | 268 | 223 |
| Cash Flow from Investing Activities | -189 | -222 | -95 | -55 |
| Cash Flow from Financing Activitie | -12 | 241 | -172 | -166 |
| Net Cash Inflow / Outflow | 27 | 4 | 1 | 2 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 25.38.
- 3Y Stock Price CAGR of the stock is -0.8.
- The stock has a beta of 1.0.
- In the last financial year, the company had an EBITDA of ₹346 Million.
- The company generated revenue of ₹3392 Million in the previous financial year.
Bal Pharma
118.721.3 (1.1%)
Investment Amount: ₹ 11755
Current Value: ₹ 11872
Performance: 1%
P/L: ₹ 117
Top Gainers
| Symbol | Change% |
|---|---|
| NURECA | 380.7(18%) |
| CUBEXTUB | 96.84(16%) |
| MAZDA | 1969.9(14%) |
| ATLASCYCLE | 112.81(10%) |
| DNAMEDIA | 6.99(10%) |
Top Losers
| Symbol | Change% |
|---|---|
| GTPL | 130.53(-11%) |
| GRWRHITECH | 4286.15(-10%) |
| AWL | 291.1(-10%) |
| SPANDANA | 405.8(-10%) |
| JAICORPLTD | 173(-10%) |
| DISHTV | 8.86(-10%) |
| HARRMALAYA | 284.45(-9%) |
| KAMDHENU | 46.4(-9%) |
Similar stocks
Announcing Stock of the Month!
